The UK Government has said genomics expertise will be offered to countries around the world to identify new variants of SARS-CoV-2.
List view / Grid view
Public Health England (PHE)
According to a Public Health England study, prior SARS-CoV-2 infection provides 83 percent protection against reinfection but may not stop individuals spreading COVID-19.
The UK National Institute of Health Research (NIHR) and UK Research and Innovation (UKRI) wish to fund research exploring if people from black, Asian and middle eastern backgrounds are disproportionately at risk from COVID-19.
Lyme disease – an infection contracted from the bite of an infected tick– is an important emerging disease in the UK, and is increasing in incidence in people in the UK and large parts of Europe and North America.
27 October 2016 | By Niamh Louise Marriott, Digital Content Producer
NHS England has announced a £42m fund to support pharmacy to transform how it operates across the NHS for the benefit of patients over the next two years...
9 July 2015 | By Victoria White
The transfer of PHE's clinical drug development and production capability into Porton Biopharma Ltd has been approved by the Secretary of State for Health...